ACLY and neoplasm: In the case of SIRT6, the two-pronged regulation of both histone deacetylation and ACLY-dependent histone acetylation may help maintain the stability of tumor suppressive gene expression programs and protect against potential effects of metabolic fluctuations on SIRT6 or ACLY activity.